Larcaviximab, CAS 1792982-56-9

Product Description: Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 30, No. 4, 2016.

CAS Number: 1792982-56-9

Molecular Weight: N/A

Compound Purity: 96.13

Research Area: Infection

Solubility: H2O

Target: Filovirus

• Artikelnummer: MEXHY-P99686-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99686-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated